MIME-Version: 1.0
Content-Location: file:///C:/786B0A96/8932a79a349b4e1793adbd9cad9e3a36.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="utf-8"

<html xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:dt=3D"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dutf-8">
<meta name=3DProgId content=3DOneNote.File>
<meta name=3DGenerator content=3D"Microsoft OneNote 15">
<link id=3DMain-File rel=3DMain-File href=3D8932a79a349b4e1793adbd9cad9e3a36.htm>
<link rel=3DFile-List href=3D"8932a79a349b4e1793adbd9cad9e3a36.files/filelist.xml">
</head>

<body lang=3Dzh-TW style=3D'font-family:Calibri;font-size:11.0pt'>

<div style=3D'direction:ltr;border-width:100%'>

<div style=3D'direction:ltr;margin-top:0in;margin-left:0in;width:6.9111in'>

<div style=3D'direction:ltr;margin-top:0in;margin-left:.3069in;width:1.4569in'>

<p style=3D'margin:0in;font-size:20.0pt'><span style=3D'font-family:"Microsoft JhengHei"'
lang=3Dzh-TW>示範</span><span style=3D'font-family:Calibri' lang=3Den-US>ITP</span></p>

</div>

<div style=3D'direction:ltr;margin-top:.0388in;margin-left:.3069in;width:1.9423in'>

<p style=3D'margin:0in;font-size:10.0pt;color:#767676'><span style=3D'font-family:
Calibri'>2025</span><span style=3D'font-family:"Microsoft JhengHei"'>年</span><span
style=3D'font-family:Calibri'>2</span><span style=3D'font-family:"Microsoft JhengHei"'>月</span><span
style=3D'font-family:Calibri'>4</span><span style=3D'font-family:"Microsoft JhengHei"'>日</span></p>

<p style=3D'margin:0in;font-size:10.0pt;color:#767676'><span style=3D'font-family:
"Microsoft JhengHei"'>下午</span><span style=3D'font-family:Calibri'> 07:55</span></p>

</div>

<div style=3D'direction:ltr;margin-top:.4687in;margin-left:0in;width:6.9111in'>

<ul style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:0in'>
 <ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;background:
      yellow;mso-highlight:yellow' lang=3Dzh-TW>immune thromboc</span><span
      style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;background:
      yellow;mso-highlight:yellow' lang=3Den-US>y</span><span style=3D'font-weight:
      bold;font-family:微軟正黑體;font-size:11.0pt;background:yellow;mso-highlight:
      yellow' lang=3Dzh-TW>topenic purpura</span><span style=3D'font-weight:bold;
      font-family:微軟正黑體;font-size:11.0pt;background:yellow;mso-highlight:yellow'
      lang=3Den-US>(ITP)</span><span style=3D'font-family:微軟正黑體;font-size:11.0pt'
      lang=3Dzh-TW>：</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt'>定義：找不出原因的isolated
       thrombocytopenia(&lt; 100,000/mm3)</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt'>Newly diagnosed ITP：診斷後前 3
        個月</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>Persistent ITP：持續</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US> 3-12 </span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>個月</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>Chronic ITP：持續</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US> &gt; 12 </span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>個月</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt'>流行病學：</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt'>兒童：</span></li>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>&lt; 5</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>歲</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>prevalence</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>最高</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>Self-limiting</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>：</span><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#C00000'
         lang=3Dzh-TW>病毒感染</span><span style=3D'font-family:微軟正黑體;font-size:11.0pt'
         lang=3Dzh-TW>後消失</span></li>
    </ul>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'
         lang=3Den-US>80%</span><span style=3D'font-weight:bold;font-family:微軟正黑體;
         font-size:11.0pt' lang=3Dzh-TW>在</span><span style=3D'font-weight:bold;
         font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>12</span><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'
         lang=3Dzh-TW>個月內消退</span></li>
    </ul>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt'>成人：</span></li>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>&gt;55</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>歲</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>prevalence</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>最高</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>80%</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>發展成</span><a
         href=3D"onenote:#&#129658;疾病|凝血相關疾病&amp;section-id=3D{F4BD5699-E3A3-4D0A-995D-58AB93A64C6C}&amp;page-id=3D{50AE51A6-0587-42F2-90A2-8CE646200224}&amp;object-id=3D{DFC3F6F1-EE87-4630-9740-8AFD7903EA5D}&amp;25&amp;base-path=3Dhttps://d.docs.live.net/56ce32fba64785ca/臨床筆記/HEMA%5eJ%20ONCO.one"><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>Chronic ITP</span></a></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt'>25% 由CBC檢查偶然發現</span></li>
    </ul>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>病生理：身體中產生</span><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#C00000'
       lang=3Dzh-TW>血小板抗體</span><span style=3D'font-weight:bold;font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000' lang=3Den-US>(Anti-PLT Ab)</span><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>(</span><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>通常是</span><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>IgG</span><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>直接接上</span><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>Plt</span><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>表面蛋白攻擊</span><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>)</span><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>→送到肝脾處理→</span><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#C00000'
       lang=3Dzh-TW>骨髓</span><span style=3D'font-weight:bold;font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000' lang=3Den-US>megakaryocyte</span><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#C00000'
       lang=3Dzh-TW>、</span><span style=3D'font-weight:bold;font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000' lang=3Den-US>Plt</span><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#C00000'
       lang=3Dzh-TW>製造增加</span><span style=3D'font-weight:bold;font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000' lang=3Den-US>(</span><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#C00000'
       lang=3Dzh-TW>絕大多數</span><span style=3D'font-weight:bold;font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000' lang=3Den-US>) </span><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>[</span><a
       href=3D"onenote:基礎生理.one#過敏反應&amp;section-id=3D{EB04CCEF-7970-4EE5-96FE-D4EF960010B4}&amp;page-id=3D{B444B81C-7EE9-4EAD-9D6E-6224BFFE2E9E}&amp;object-id=3D{4D15FA70-8C1E-4AC6-AB70-EB0D0ACC2547}&amp;67&amp;base-path=3Dhttps://d.docs.live.net/56ce32fba64785ca/臨床筆記"><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>Type
       2過敏</span></a><span style=3D'font-weight:bold;font-family:微軟正黑體;
       font-size:11.0pt' lang=3Den-US>]</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt'>病因：</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>Primary</span><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>：</span><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>idiopathic(</span><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>最常見</span><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>)</span></li>
   </ul>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>Secondary</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>：</span></li>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>Autoimmune：</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>SLE</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>、</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>Anti-phospholipid
         syndrome</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>感染：</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>HIV</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>、</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>HCV</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>、</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>EBV</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>、</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>VZV</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>惡性腫瘤：</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>Lymphoma</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>、</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>Leukemia(</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>特別是</span><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>CLL)</span></li>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style=3D'font-family:微軟正黑體;font-size:11.0pt'>藥物：quinine, beta-lactam
         antibiotics, carbamazepine, heparin, vaccines, linezolid,
         sulfonamides, vancomycin, TMP-SMX, antiepileptics </span></li>
    </ul>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>臨床表現：</span><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#C00000'
       lang=3Dzh-TW>好發病毒感染後</span><span style=3D'font-weight:bold;font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000' lang=3Den-US>1-4</span><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#C00000'
       lang=3Dzh-TW>週</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt'>最常見：無症狀、無脾臟腫大</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt'>輕微表皮、黏膜出血</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt'>診斷：</span><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>排除性診斷</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>先排除其他次發性原因，Anti-plt</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US> </span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>Ab低敏感度、低專一性</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>治療：血小板</span><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#C00000'
       lang=3Den-US>&lt;50000</span><span style=3D'font-weight:bold;font-family:
       微軟正黑體;font-size:11.0pt;color:#C00000' lang=3Dzh-TW>出血嚴重</span><span
       style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>，</span><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#ED7D31'
       lang=3Dzh-TW>或</span><span style=3D'font-weight:bold;font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000' lang=3Den-US>&lt;30000</span><span
       style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#C00000'
       lang=3Dzh-TW>才需治療</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>第一線藥物：</span><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#70AD47'
        lang=3Dzh-TW>類固醇</span><span style=3D'font-family:微軟正黑體;font-size:11.0pt'
        lang=3Den-US>(</span><span style=3D'font-family:微軟正黑體;font-size:11.0pt'
        lang=3Dzh-TW>治療到</span><span style=3D'font-family:微軟正黑體;font-size:11.0pt'
        lang=3Den-US>Plt &gt; 50000)</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt'>嚴重出血病人考慮合併IVIG</span></li>
    <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'
         lang=3Dzh-TW>明顯急性出血可輸血小板，若出血仍不止可考慮Recombinant factor V</span><span
         style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'
         lang=3Den-US>IIa</span></li>
    </ul>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>其他治療：</span><span
        style=3D'font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#70AD47'
        lang=3Dzh-TW>rituximab</span><span style=3D'font-family:微軟正黑體;font-size:
        11.0pt' lang=3Dzh-TW>、TPO receptor agonist</span><span style=3D'font-family:
        微軟正黑體;font-size:11.0pt' lang=3Den-US>(</span><span style=3D'font-weight:
        bold;font-family:微軟正黑體;font-size:11.0pt;color:#70AD47' lang=3Dzh-TW>Romiplostim、Eltrombopag</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>)</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>、Splenectomy</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>(</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>治療無效超過</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>1</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>年</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US>)</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>、</span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Den-US> </span><span
        style=3D'font-family:微軟正黑體;font-size:11.0pt' lang=3Dzh-TW>Danazol、Azathioprine、Cyclophosphomide、MMF、Cyclosporin
        </span></li>
   </ul>
  </ul>
 </ul>
</ul>

</div>

</div>

</div>

<div>

<p style=3D'margin:0in'>&nbsp;</p>

<p style=3D'text-align:left;margin:0in;font-family:Arial;font-size:9pt;
color:#969696;direction:ltr'>使用 OneNote 建立。</p>

</div>

</body>

</html>
